The choice of serum‐free light chain analysis method could potentially have clinical consequences for myeloma patients von Veskovski, Ljupco, Jakobsson, Ingvar, Andersson, Per‐Ola, Gustafsson, Therese, Sedigh, Annelie, Knut‐Bojanowska, Dorota, Hansson, Markus, Hveding Blimark, Cecilie, Mellqvist, Ulf‐Henrik

Volltext

Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study von Wålinder, Göran, Genell, Anna, Juliusson, Gunnar, Svensson, Ronald, Santamaria, Antonio Izarra, Crafoord, Jacob, Carlson, Kristina, Knut‐Bojanowska, Dorota, Veskovski, Ljupco, Lauri, Birgitta, Lund, Johan, Turesson, Ingemar, Hansson, Markus, Blimark, Cecilie Hveding, Nahi, Hareth

Volltext

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre... von San-Miguel, Jesús F, Prof, Hungria, Vânia T M, MD, Yoon, Sung-Soo, Prof, Beksac, Meral, Prof, Dimopoulos, Meletios Athanasios, Prof, Elghandour, Ashraf, Prof, Jedrzejczak, Wieslaw Wiktor, Prof, Günther, Andreas, MD, Nakorn, Thanyaphong Na, MD, Siritanaratkul, Noppadol, MD, Corradini, Paolo, Prof, Chuncharunee, Suporn, MD, Lee, Je-Jung, Prof, Schlossman, Robert L, MD, Shelekhova, Tatiana, PhD, Yong, Kwee, Prof, Tan, Daryl, MRCP, Numbenjapon, Tontanai, MD, Cavenagh, Jamie D, MD, Hou, Jian, Prof, LeBlanc, Richard, MD, Nahi, Hareth, Prof, Qiu, Lugui, Prof, Salwender, Hans, MD, Pulini, Stefano, MD, Moreau, Philippe, Prof, Warzocha, Krzysztof, Prof, White, Darrell, Prof, Bladé, Joan, MD, Chen, WenMing, Prof, de la Rubia, Javier, Prof, Gimsing, Peter, MD, Lonial, Sagar, Prof, Kaufman, Jonathan L, MD, Ocio, Enrique M, MD, Veskovski, Ljupco, MD, Sohn, Sang Kyun, Prof, Wang, Ming-Chung, MD, Lee, Jae Hoon, Prof, Einsele, Hermann, Prof, Sopala, Monika, PhD, Corrado, Claudia, MD, Bengoudifa, Bourras-Rezki, MS, Binlich, Florence, MD, Richardson, Paul G, Prof

Volltext

Serum metabolomic profiling correlated with ISS and clinical outcome for multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation von Veskovski, Ljupco, Andersson, Per-Ola, Turesson, Ingemar, Malmodin, Daniel, Pedersen, Anders, Mellqvist, Ulf-Henrik

Volltext

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation von Veskovski, Ljupco, Andersson, Per-Ola, Turesson, Ingemar, Malmodin, Daniel, Pedersen, Anders, Mellqvist, Ulf-Henrik

Volltext

P-184: Regional differences in treatment and outcome for myeloma patients in Sweden: a population based Swedish Myeloma Register study von Wålinder, Göran, Genell, Anna, Juliusson, Gunnar, Svensson, Ronald, Santamaria, Antonio, Crafoord, Jacob, Carlson, Kristina, Knut-Bojanowska, Dorota, Veskovski, Ljupco, Lauri, Birgitta, Lund, Johan, Turesson, Ingemar, Hansson, Markus, Blimark, Cecilie Hveding, Nahi, Hareth

Volltext

Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden von Ali, Mina, Lemonakis, Konstantinos, Wihlborg, Anna-Karin, Veskovski, Ljupco, Turesson, Ingemar, Mellqvist, Ulf-Henrik, Gullberg, Urban, Hansson, Markus, Nilsson, Björn

Volltext

Melphalan 100mg/m(2) with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation von Blimark, Cecilie, Veskovski, Ljupco, Westin, Jan, Rödjer, Stig, Brune, Mats, Hjorth, Martin, Holmberg, Erik, Andersson, Per-Ola, Mellqvist, Ulf-Henrik

Volltext

Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation: Mel... von Blimark, Cecilie, Veskovski, Ljupco, Westin, Jan, Rödjer, Stig, Brune, Mats, Hjorth, Martin, Holmberg, Erik, Andersson, Per-Ola, Mellqvist, Ulf-Henrik

Volltext

Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation von Blimark, Cecilie, Veskovski, Ljupco, Westin, Jan, Rödjer, Stig, Brune, Mats, Hjorth, Martin, Holmberg, Erik, Andersson, Per-Ola, Mellqvist, Ulf-Henrik

Volltext